Published in AIDS on August 24, 2013
Global and National Burden of Diseases and Injuries Among Children and Adolescents Between 1990 and 2013: Findings From the Global Burden of Disease 2013 Study. JAMA Pediatr (2016) 2.19
Age Targeting of Voluntary Medical Male Circumcision Programs Using the Decision Makers' Program Planning Toolkit (DMPPT) 2.0. PLoS One (2016) 1.61
Estimates of global, regional, and national incidence, prevalence, and mortality of HIV, 1980-2015: the Global Burden of Disease Study 2015. Lancet HIV (2016) 1.51
Shared learning in an interconnected world: innovations to advance global health equity. Global Health (2013) 1.30
Global epidemiology of tuberculosis. Cold Spring Harb Perspect Med (2014) 1.11
Recent HIV prevalence trends among pregnant women and all women in sub-Saharan Africa: implications for HIV estimates. AIDS (2014) 1.06
Reliability and validity of depression assessment among persons with HIV in sub-Saharan Africa: systematic review and meta-analysis. J Acquir Immune Defic Syndr (2014) 1.03
How have ART treatment programmes changed the patterns of excess mortality in people living with HIV? Estimates from four countries in East and Southern Africa. Glob Health Action (2014) 1.00
Burden of disease measured by disability-adjusted life years and a disease forecasting time series model of scrub typhus in Laiwu, China. PLoS Negl Trop Dis (2015) 0.85
Cost-effectiveness of tenofovir gel in urban South Africa: model projections of HIV impact and threshold product prices. BMC Infect Dis (2014) 0.85
HIV Prevalence, Estimated Incidence, and Risk Behaviors Among People Who Inject Drugs in Kenya. J Acquir Immune Defic Syndr (2015) 0.83
Association between intoxication at last sexual intercourse and unprotected sex among men and women in Uganda. J Infect Dev Ctries (2014) 0.80
Combining Cell and Gene Therapy in an Effort to Eradicate HIV. AIDS Patient Care STDS (2016) 0.80
Mental and substance use disorders in Sub-Saharan Africa: predictions of epidemiological changes and mental health workforce requirements for the next 40 years. PLoS One (2014) 0.80
Getting to zero HIV deaths: progress, challenges and ways forward. J Int AIDS Soc (2013) 0.80
Intoxication at last sexual intercourse and unprotected sex among HIV-positive and HIV-negative individuals in Uganda: an event-level analysis. AIDS Behav (2015) 0.78
Optimizing an HIV testing program using a system dynamics model of the continuum of care. Health Care Manag Sci (2015) 0.78
The Burden of Zoonoses in Kyrgyzstan: A Systematic Review. PLoS Negl Trop Dis (2016) 0.77
ART attrition and risk factors among Option B+ patients in Haiti: A retrospective cohort study. PLoS One (2017) 0.77
Neuroimaging abnormalities and seizure recurrence in a prospective cohort study of zambians with human immunodeficiency virus and first seizure. Neurol Int (2014) 0.77
HIV and/or AIDS-related deaths and modifiable risk factors: A descriptive study of medical admissions at Oshakati Intermediate Hospital in Northern Namibia. Afr J Prim Health Care Fam Med (2015) 0.77
The clock is ticking: the rate and timeliness of antiretroviral therapy initiation from the time of treatment eligibility in Kenya. J Int AIDS Soc (2015) 0.75
Delayed entry into HIV care after diagnosis in two specialized care and treatment centres in Cameroon: the influence of CD4 count and WHO staging. BMC Public Health (2016) 0.75
HIV Diagnosis and Treatment through Advanced Technologies. Front Public Health (2017) 0.75
Resveratrol Co-Treatment Attenuates the Effects of HIV Protease Inhibitors on Rat Body Weight and Enhances Cardiac Mitochondrial Respiration. PLoS One (2017) 0.75
Assessment of HIV/AIDS comprehensive correct knowledge among Sudanese university: a cross-sectional analytic study 2014. Pan Afr Med J (2016) 0.75
Ideal Cardiovascular Health and Carotid Atherosclerosis in a Mixed Cohort of HIV-Infected and Uninfected Ugandans. AIDS Res Hum Retroviruses (2016) 0.75
The CD4 C868T Polymorphism and Its Correlation with HIV-1 Infection in a Chinese Population. AIDS Res Hum Retroviruses (2015) 0.75
Impact of a primary care national policy on HIV screening in France: a longitudinal analysis between 2006 and 2013. Br J Gen Pract (2016) 0.75
National nursing and midwifery legislation in countries of South-East Asia with high HIV burdens. WHO South East Asia J Public Health (2015) 0.75
Putting the burden of HIV in context. AIDS (2013) 0.75
Mortality from tetanus between 1990 and 2015: findings from the global burden of disease study 2015. BMC Public Health (2017) 0.75
HIV and/or AIDS-related deaths and modifiable risk factors: A descriptive study of medical admissions at Oshakati Intermediate Hospital in Northern Namibia. Afr J Prim Health Care Fam Med (2015) 0.75
Objective impairments of gait and balance in adults living with HIV-1 infection: a systematic review and meta-analysis of observational studies. BMC Musculoskelet Disord (2017) 0.75
Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet (2012) 56.72
Disability-adjusted life years (DALYs) for 291 diseases and injuries in 21 regions, 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet (2012) 41.47
Years lived with disability (YLDs) for 1160 sequelae of 289 diseases and injuries 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet (2012) 26.95
Rapid scale-up of antiretroviral therapy at primary care sites in Zambia: feasibility and early outcomes. JAMA (2006) 17.93
Towards an improved investment approach for an effective response to HIV/AIDS. Lancet (2011) 11.89
Common values in assessing health outcomes from disease and injury: disability weights measurement study for the Global Burden of Disease Study 2010. Lancet (2012) 11.32
Mortality and morbidity from malaria in Gambian children after introduction of an impregnated bednet programme. Lancet (1995) 8.71
GBD 2010: design, definitions, and metrics. Lancet (2012) 8.64
Healthy life expectancy for 187 countries, 1990-2010: a systematic analysis for the Global Burden Disease Study 2010. Lancet (2012) 8.22
Effect of expanded insecticide-treated bednet coverage on child survival in rural Kenya: a longitudinal study. Lancet (2007) 7.98
Age-specific and sex-specific mortality in 187 countries, 1970-2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet (2012) 7.62
Cost-effectiveness of voluntary HIV-1 counselling and testing in reducing sexual transmission of HIV-1 in Kenya and Tanzania. Lancet (2000) 6.61
Cost-effectiveness of HIV/AIDS interventions in Africa: a systematic review of the evidence. Lancet (2002) 6.47
The Spectrum projection package: improvements in estimating mortality, ART needs, PMTCT impact and uncertainty bounds. Sex Transm Infect (2008) 5.98
Prevention of mother-to-child transmission of HIV and the health-related Millennium Development Goals: time for a public health approach. Lancet (2011) 5.00
Mortality in HIV-infected Ugandan adults receiving antiretroviral treatment and survival of their HIV-uninfected children: a prospective cohort study. Lancet (2008) 4.70
Cost-effectiveness of male circumcision for HIV prevention in a South African setting. PLoS Med (2006) 4.34
Worldwide mortality in men and women aged 15-59 years from 1970 to 2010: a systematic analysis. Lancet (2010) 3.89
Modeling causes of death: an integrated approach using CODEm. Popul Health Metr (2012) 3.12
The Spectrum projection package: improvements in estimating incidence by age and sex, mother-to-child transmission, HIV progression in children and double orphans. Sex Transm Infect (2010) 2.95
Updates to the Spectrum/Estimation and Projection Package (EPP) model to estimate HIV trends for adults and children. Sex Transm Infect (2012) 2.88
Rapid scale-up of antiretroviral treatment in Ethiopia: successes and system-wide effects. PLoS Med (2009) 2.52
A strategic revolution in HIV and global health. Lancet (2011) 2.21
Scale-up of HIV treatment through PEPFAR: a historic public health achievement. J Acquir Immune Defic Syndr (2012) 1.78
GBD 2010: a multi-investigator collaboration for global comparative descriptive epidemiology. Lancet (2012) 1.77
GBD 2010 country results: a global public good. Lancet (2013) 1.28
Positive spill-over effects of ART scale up on wider health systems development: evidence from Ethiopia and Malawi. J Int AIDS Soc (2011) 1.22
Population health metrics: crucial inputs to the development of evidence for health policy. Popul Health Metr (2003) 1.16
Long-term costs and health impact of continued global fund support for antiretroviral therapy. PLoS One (2011) 1.16
Mortality from HIV in the Global Burden of Disease study - authors' reply. Lancet (2013) 0.89
Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet (2012) 56.72
Disability-adjusted life years (DALYs) for 291 diseases and injuries in 21 regions, 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet (2012) 41.47
Global and regional burden of disease and risk factors, 2001: systematic analysis of population health data. Lancet (2006) 37.83
Maternal mortality for 181 countries, 1980-2008: a systematic analysis of progress towards Millennium Development Goal 5. Lancet (2010) 33.69
Years lived with disability (YLDs) for 1160 sequelae of 289 diseases and injuries 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet (2012) 26.95
Selected major risk factors and global and regional burden of disease. Lancet (2002) 24.47
Household catastrophic health expenditure: a multicountry analysis. Lancet (2003) 20.07
Global malaria mortality between 1980 and 2010: a systematic analysis. Lancet (2012) 17.62
Global burden of disease attributable to mental and substance use disorders: findings from the Global Burden of Disease Study 2010. Lancet (2013) 16.76
Progress towards Millennium Development Goals 4 and 5 on maternal and child mortality: an updated systematic analysis. Lancet (2011) 14.16
Financing of global health: tracking development assistance for health from 1990 to 2007. Lancet (2009) 13.41
Neonatal, postneonatal, childhood, and under-5 mortality for 187 countries, 1970-2010: a systematic analysis of progress towards Millennium Development Goal 4. Lancet (2010) 12.28
The preventable causes of death in the United States: comparative risk assessment of dietary, lifestyle, and metabolic risk factors. PLoS Med (2009) 12.13
Common values in assessing health outcomes from disease and injury: disability weights measurement study for the Global Burden of Disease Study 2010. Lancet (2012) 11.32
Public financing of health in developing countries: a cross-national systematic analysis. Lancet (2010) 11.22
The state of US health, 1990-2010: burden of diseases, injuries, and risk factors. JAMA (2013) 10.43
GBD 2010: design, definitions, and metrics. Lancet (2012) 8.64
Healthy life expectancy for 187 countries, 1990-2010: a systematic analysis for the Global Burden Disease Study 2010. Lancet (2012) 8.22
Breast and cervical cancer in 187 countries between 1980 and 2010: a systematic analysis. Lancet (2011) 7.71
Rapid health transition in China, 1990-2010: findings from the Global Burden of Disease Study 2010. Lancet (2013) 7.70
Age-specific and sex-specific mortality in 187 countries, 1970-2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet (2012) 7.62
Causes of cancer in the world: comparative risk assessment of nine behavioural and environmental risk factors. Lancet (2005) 6.63
Trends in national and state-level obesity in the USA after correction for self-report bias: analysis of health surveys. J R Soc Med (2006) 6.11
UK health performance: findings of the Global Burden of Disease Study 2010. Lancet (2013) 6.11
Burden of depressive disorders by country, sex, age, and year: findings from the global burden of disease study 2010. PLoS Med (2013) 6.04
Increased educational attainment and its effect on child mortality in 175 countries between 1970 and 2009: a systematic analysis. Lancet (2010) 5.36
Estimates of global and regional potential health gains from reducing multiple major risk factors. Lancet (2003) 5.26
Rethinking the "diseases of affluence" paradigm: global patterns of nutritional risks in relation to economic development. PLoS Med (2005) 4.64
Worldwide epidemiology of atrial fibrillation: a Global Burden of Disease 2010 Study. Circulation (2013) 4.60
Global and regional mortality from ischaemic heart disease and stroke attributable to higher-than-optimum blood glucose concentration: comparative risk assessment. Lancet (2006) 4.26
Prevention of cardiovascular disease in high-risk individuals in low-income and middle-income countries: health effects and costs. Lancet (2007) 4.15
Comparability of self rated health: cross sectional multi-country survey using anchoring vignettes. BMJ (2004) 3.94
A systematic analysis of global anemia burden from 1990 to 2010. Blood (2013) 3.94
Health Effects of Overweight and Obesity in 195 Countries over 25 Years. N Engl J Med (2017) 3.90
Worldwide mortality in men and women aged 15-59 years from 1970 to 2010: a systematic analysis. Lancet (2010) 3.89
Improvement of child survival in Mexico: the diagonal approach. Lancet (2006) 3.87
The reversal of fortunes: trends in county mortality and cross-county mortality disparities in the United States. PLoS Med (2008) 3.73
Global burden of disease attributable to illicit drug use and dependence: findings from the Global Burden of Disease Study 2010. Lancet (2013) 3.65
Setting international standards for verbal autopsy. Bull World Health Organ (2007) 3.59
WHO Framework Convention on Tobacco Control: development of an evidence based global public health treaty. BMJ (2003) 3.42
Assessment of population-level effect of Avahan, an HIV-prevention initiative in India. Lancet (2011) 3.39
Assessing the effect of the 2001-06 Mexican health reform: an interim report card. Lancet (2006) 3.33
Net benefits: a multicountry analysis of observational data examining associations between insecticide-treated mosquito nets and health outcomes. PLoS Med (2011) 3.32
Global and regional estimates of cancer mortality and incidence by site: II. Results for the global burden of disease 2000. BMC Cancer (2002) 3.26
Population Health Metrics Research Consortium gold standard verbal autopsy validation study: design, implementation, and development of analysis datasets. Popul Health Metr (2011) 3.21
Modeling causes of death: an integrated approach using CODEm. Popul Health Metr (2012) 3.12
Robust metrics for assessing the performance of different verbal autopsy cause assignment methods in validation studies. Popul Health Metr (2011) 3.10
Benchmarking of performance of Mexican states with effective coverage. Lancet (2006) 3.06
The global burden of ischemic heart disease in 1990 and 2010: the Global Burden of Disease 2010 study. Circulation (2014) 2.99
Limitations of methods for measuring out-of-pocket and catastrophic private health expenditures. Bull World Health Organ (2009) 2.89
Are Americans feeling less healthy? The puzzle of trends in self-rated health. Am J Epidemiol (2009) 2.88
Distribution of major health risks: findings from the Global Burden of Disease study. PLoS Med (2004) 2.84
Access, utilization, quality, and effective coverage: an integrated conceptual framework and measurement strategy. Soc Sci Med (2005) 2.78
Absorptive capacity and disbursements by the Global Fund to Fight AIDS, Tuberculosis and Malaria: analysis of grant implementation. Lancet (2006) 2.67
Algorithms for enhancing public health utility of national causes-of-death data. Popul Health Metr (2010) 2.67
Temporal trends in ischemic heart disease mortality in 21 world regions, 1980 to 2010: the Global Burden of Disease 2010 study. Circulation (2014) 2.66
Trends and cardiovascular mortality effects of state-level blood pressure and uncontrolled hypertension in the United States. Circulation (2008) 2.65
Effectiveness of diabetes and hypertension management by rural primary health-care workers (Behvarz workers) in Iran: a nationally representative observational study. Lancet (2011) 2.61
Assessing the burden of disease in the United States using disability-adjusted life years. Am J Prev Med (2005) 2.40
Using verbal autopsy to measure causes of death: the comparative performance of existing methods. BMC Med (2014) 2.39
Effect of the Global Alliance for Vaccines and Immunisation on diphtheria, tetanus, and pertussis vaccine coverage: an independent assessment. Lancet (2006) 2.35
Measuring adult mortality using sibling survival: a new analytical method and new results for 44 countries, 1974-2006. PLoS Med (2010) 2.32
The burden of disease and injury in the United States 1996. Popul Health Metr (2006) 2.27
Global health development assistance remained steady in 2013 but did not align with recipients' disease burden. Health Aff (Millwood) (2014) 2.26
The global financial crisis has led to a slowdown in growth of funding to improve health in many developing countries. Health Aff (Millwood) (2011) 2.21
Measuring under-five mortality: validation of new low-cost methods. PLoS Med (2010) 2.14
A multi-method approach to measuring health-state valuations. Health Econ (2004) 2.10
Should data from demographic surveillance systems be made more widely available to researchers? PLoS Med (2008) 2.06
Management of diabetes and associated cardiovascular risk factors in seven countries: a comparison of data from national health examination surveys. Bull World Health Organ (2010) 1.84
Prevalence, awareness, treatment, and control of hypertension in United States counties, 2001-2009. PLoS One (2013) 1.81
The promise of prevention: the effects of four preventable risk factors on national life expectancy and life expectancy disparities by race and county in the United States. PLoS Med (2010) 1.78
GBD 2010: a multi-investigator collaboration for global comparative descriptive epidemiology. Lancet (2012) 1.77
Has the DOTS strategy improved case finding or treatment success? An empirical assessment. PLoS One (2008) 1.74
Demographic and epidemiologic drivers of global cardiovascular mortality. N Engl J Med (2015) 1.70
Liver cirrhosis mortality in 187 countries between 1980 and 2010: a systematic analysis. BMC Med (2014) 1.66
Incorporating loss to follow-up in estimates of survival among HIV-infected individuals in sub-Saharan Africa enrolled in antiretroviral therapy programs. J Infect Dis (2012) 1.65
Fifty years of violent war deaths from Vietnam to Bosnia: analysis of data from the world health survey programme. BMJ (2008) 1.61
Impact of insurance and supply of health professionals on coverage of treatment for hypertension in Mexico: population based study. BMJ (2007) 1.60
Simplified Symptom Pattern Method for verbal autopsy analysis: multisite validation study using clinical diagnostic gold standards. Popul Health Metr (2011) 1.54
Improving the comparability of diabetes mortality statistics in the U.S. and Mexico. Diabetes Care (2007) 1.52
Estimates of global, regional, and national incidence, prevalence, and mortality of HIV, 1980-2015: the Global Burden of Disease Study 2015. Lancet HIV (2016) 1.51